 |
|
U of MN researchers link early brain development to adult-onset neurodegenerative disease
November 17, 2006Researchers at the University of Minnesota's Institute for Human Genetics have shown for the first time that the severity of an adult neurodegenerative disease is tied to how well the brain developed shortly after birth.
The researchers used a mouse model for spinocerebellar ataxia type 1 (SCA 1), a fatal neurodegenerative disease that is associated with the loss of coordination that affects activities such as walking, speaking and swallowing. There is no treatment for this disease, and patients typically die 10-15 years after their first symptoms appear.
"We always suspected that something was going on with the SCA 1 mice developmentally," said Harry Orr, Ph.D., professor of genetics, cell biology and development. "Now, we have the data to support it."
The research will appear in the Nov. 17, 2006 issue of the journal Cell.
Orr and his team manipulated the mouse model for the disease so that the gene that causes SCA 1 could be turned on and off.
In one group of mice, they turned off the gene for approximately two weeks at the beginning of the mice's development; then it was turned back on. In the second group of mice, they left the gene on for the entire time.
After 12 weeks, the researchers observed the mice.
"The difference was dramatic," Orr said.
The mice in the group in which the gene was turned off appeared virtually normal, while the mice in the other group had difficulty standing and walking. Orr said that the discovery suggests that in the future, doctors may be able to target treatment to coincide with critical times in development, lessening the impact of a disease in which symptoms take years to appear.
Although SCA 1 appears later in life, it is possible to do genetic screening at birth to determine if a person is at risk for getting the disease in adulthood.
The researchers next will look into the specific molecular pathways involved in early brain development, Orr said. He added that that in the future, research into the proteins and protein expression may be translated into therapeutic approaches.
University of Minnesota
The research will appear in the Nov. 17, 2006 issue of the journal Cell.
Orr and his team manipulated the mouse model for the disease so that the gene that causes SCA 1 could be turned on and off.
In one group of mice, they turned off the gene for approximately two weeks at the beginning of the mice's development; then it was turned back on. In the second group of mice, they left the gene on for the entire time.
After 12 weeks, the researchers observed the mice.
"The difference was dramatic," Orr said.
The mice in the group in which the gene was turned off appeared virtually normal, while the mice in the other group had difficulty standing and walking. Orr said that the discovery suggests that in the future, doctors may be able to target treatment to coincide with critical times in development, lessening the impact of a disease in which symptoms take years to appear.
Although SCA 1 appears later in life, it is possible to do genetic screening at birth to determine if a person is at risk for getting the disease in adulthood.
The researchers next will look into the specific molecular pathways involved in early brain development, Orr said. He added that that in the future, research into the proteins and protein expression may be translated into therapeutic approaches.
University of Minnesota
Neurodegenerative Disease Current Events and Neurodegenerative Disease News RSSNovel mouse gene reduces major pathologies associated with Alzheimer's disease
A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD).
Mouse gene suppresses Alzheimer's plaques and tangles
Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau.
Widely used cholesterol-lowering drug may prevent progression
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Member of NFL Hall of Fame diagnosed with degenerative brain disease
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a recently deceased member of the NFL Hall of Fame suffered from the degenerative brain disease Chronic Traumatic Encephalopathy (CTE) when he died, becoming the 10th former NFL player diagnosed with the disease.
First former college football player diagnosed with CTE
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a deceased former college football player who died at age 42 was already suffering from the degenerative brain disease, Chronic Traumatic Encephalopathy (CTE).
Natural compounds, chemotherapeutic drugs may become partners in cancer therapy
Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy.
August 10, 2009 New Class of Compounds Discovered for Potential Alzheimer's Disease Drug, Penn Study Finds
A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer's disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine.
Caffeine reverses memory impairment in Alzheimer's mice
Coffee drinkers may have another reason to pour that extra cup. When aged mice bred to develop symptoms of Alzheimer's disease were given caffeine - the equivalent of five cups of coffee a day - their memory impairment was reversed.
Huntington's disease deciphered
Researchers at the University of Illinois at Chicago College of Medicine have discovered how the mutated huntingtin gene acts on the nervous system to create the devastation of Huntington's disease.
What separates dangerous blood vessel plaques from benign ones
Researchers say they have evidence to explain what separates your average blood vessel plaque from those that are at high risk for triggering the development of dangerous-even fatal-blood clots.
More Neurodegenerative Disease Current Events and Neurodegenerative Disease News Articles
 |
Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease) by V.M.-Y. Lee (Editor), J.Q. Trojanowski (Editor), L. Buee (Editor), Y. Christen (Editor) In this volume are contributions based on a meeting arranged by the WHO and the Fondation IPSEN. The scientists focus on neurodegenerative disorders like Alzheimer's Disease, Chromosome 17-Linked Dementia, Parkinson's Disease and disorders with tauopathies. |
 |
Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease) by Peter H. St.George-Hyslop (Editor), William C. Mobley (Editor), Yves Christen (Editor) This book explores the role of sub-cellular trafficking in the pathogenesis, treatment and prevention of neurodegenerative diseases. Recent findings point to faulty trafficking as contributing to the dysfunction and degeneration of neurons and neural circuits. Increasingly, research is targeting the mechanisms responsible and means to address them therapeutically. This book investigates the ways in which sub-cellular trafficking pathways play a role both in the pathological accumulation of these misfolded proteins and in attempts to clear them. Because subcellular protein trafficking has an important role in the biology of neuronal function and survival, this also addresses how trophic factors maintain cell, including cell interactions and how the underlying mechanisms may be compromised... |
 |
Neurodegenerative Diseases and Metal Ions: Metal Ions in Life Sciences by Astrid Sigel (Editor), Helmut Sigel (Editor), Roland K. O. Sigel (Editor) About the Series... Metal Ions in Life Sciences links coordination chemistry and biochemistry in their widest sense and thus increases our understanding of the relationship between the chemistry of metals and life processes. The series reflects the interdisciplinary nature of Biological Inorganic Chemistry and coordinates the efforts of scientists in fields like biochemistry, inorganic chemistry, coordination chemistry, molecular and structural biology, enzymology, environmental chemistry, physiology, toxicology, biophysics, pharmacy, and medicine. Consequently, the volumes are an essential source for researchers active in these and related fields as well as teachers preparing courses, e.g., in Bioinorganic Chemistry. About this Book... Volume 1, devoted... |
 |
Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases (Oxidative Stress and Disease, 1) by Montagnier (Author) Presents basic, chemical, biological, and medical studies of free radicals on different targets and the consequences of their reactivity-covering the chemistry and biochemistry of free radicals, free radicals as second messengers that group the activation of transcription factors and enzymes, the importance of the antioxidant system in cell metabolism regulation, and the role of free radicals and antioxidants in disease management. Written by over 200 international authorities, the book offers incisive discussions on the significance of oxidant-antioxidant balance and cytotoxicity of free radicals when produced in excess by several sources, specifically radiation hydrogen peroxide as a stimulant of transcription factor NFkB leading to cell response against oxidative stress ... |
 |
Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics by M. Flint Beal (Author), Anthony E. Lang (Author), Albert C. Ludolph (Author) Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and... |
 |
Neurodegenerative Diseases: From Molecular Concepts to Therapeutic Targets by Rommy Von Bernhardi (Editor), Nibaldo C. Inestrosa (Editor) This book discusses in detail the different hypothesis and experimental evidence regarding the neurobiological mechanisms involved in neurodegenerative pathology, with an emphasis in Alzheimer's and Parkinson's disease. Since there are many hypotheses for neurodegenerative diseases, there is a real need for a comprehensive view, allowing for integration of the different views for the pathogenic mechanisms of the disease. |
 |
So Much So Fast Starring: Stephen Heywood, Jamie Heywood Directed By: Steven Ascher;Jeanne Jordan What would you do if you were 29 and found you may only have a few years to live? So Much So Fast is about the remarkable events set in motion when Stephen Heywood discovers he has ALS (Lou Gehrig's disease) and his brother Jamie becomes obsessed with finding a cure. |
 |
Neural Plasticity and Repair: Special Issue: Neurodegenerative Diseases 2007 by P. Herrling (Editor) |
|
ADULTS WITH NEURODEGENERATIVE DISEASES: Occupational Therapy Practice Guidelines (Aota Practice Guidelines) by Susan Forwell (Author) | |
 |
Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases (Research and Perspectives in Alzheimer's Disease) by J. Cummings (Editor), J. Hardy (Editor), M. Poncet (Editor), Yves Christen (Editor) Recent advances in understanding the role of protein dysmetabolism in neurodegeneration was the theme of the Fondation IPSEN meeting addressing Genotype-Proteotype-Phenotype relationships. Experts from international laboratories contributed to the current volume to produce a comprehensive overview of the role of protein misfolding in neurodegeneration. Links between genotype and protein characteristics and between proteotype and clinical phenomenology were discussed across diseases categories. Progress in understanding the role of abnormalities of protein metabolism may lead to the identification of biological markers relevant to disease monitoring and to the development of new therapeutic agents capable of modifying and ameliorating basic neurodegenerative mechanisms. |
| © 2009 BrightSurf.com |